KIRKMAN ROBERT L 4
4 · Oncothyreon Inc. · Filed Dec 5, 2011
Insider Transaction Report
Form 4
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2011-12-01+100,000→ 100,000 totalExercise: $6.92Exp: 2019-12-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option is exercisable at the rate of 25% of the shares on December 1, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on December 1, 2015.